Discount rates based on industry benchmark, period Industry Benchmark, Discount Rates, Period Industry Benchmark, Discount Rates, Period Counterparties [axis] Counterparties [axis] Disclosure of classes of share capital [line items] Disclosure of classes of share capital [line items] Disclosure Of Trade And Other Receivables [Line Items] Disclosure Of Trade And Other Receivables [Line Items] Disclosure Of Trade And Other Receivables [Line Items] Issued in relation to June 2021 IPO Number Of Shares Issued In Relation To Initial Public Offering, Equity Number Of Shares Issued In Relation To Initial Public Offering, Equity Income tax Adjustments for income tax expense Fair value of plan assets at December 31 Total plan assets at fair value at December 31 Plan assets, at fair value GBP United Kingdom, Pounds Classes of financial liabilities [axis] Classes of financial liabilities [axis] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Disclosure of detailed information about intangible assets [line items] Disclosure of detailed information about intangible assets [line items] Novartis Novartis [Member] Novartis Royalty, payable Royalty, Payable Royalty, Payable Treasury share reserve Treasury shares 2028 Expiring In 2028 [Member] Expiring In 2028 Levels of fair value hierarchy [axis] Levels of fair value hierarchy [axis] Number of share options granted (in shares) Number of share options granted in share-based payment arrangement Disclosure Of Exercise Prices, Number And Weighted Average Remaining Contractual Life Of Outstanding Instruments [Line Items] Disclosure Of Exercise Prices, Number And Weighted Average Remaining Contractual Life Of Outstanding Instruments [Line Items] Disclosure Of Exercise Prices, Number And Weighted Average Remaining Contractual Life Of Outstanding Instruments Disclosure Of Detailed Information About Contract Liability [Line Items] Disclosure Of Detailed Information About Contract Liability [Line Items] Disclosure Of Detailed Information About Contract Liability Non-cash effective pension costs Post-Employment Benefit Expense, Non-Cash Effective Pension Cost Post-Employment Benefit Expense, Non-Cash Effective Pension Cost Weighted average exercise price of instruments forfeited, performance adjustment (in CHF per share) Weighted Average Exercise Price Of Instruments Forfeited In Share-Based Payment Arrangement, Non-Market Performance Conditions Not Achieved Weighted Average Exercise Price Of Instruments Forfeited In Share-Based Payment Arrangement, Non-Market Performance Conditions Not Achieved Share price (in CHF per share) Share Price Of Other Equity Instruments Granted In Share-Based Payment Arrangement Share Price Of Other Equity Instruments Granted In Share-Based Payment Arrangement Research and development expenses Research and development expenses Research and development expense Acquisition of intangible assets Purchase of intangible assets, classified as investing activities Number of employees that participated Defined Benefit Plan, Number Of Employees That Participated Defined Benefit Plan, Number Of Employees That Participated Cumulative losses Retained earnings Weighted average exercise price of share options forfeited, performance adjustment (in CHF per share) Weighted Average Exercise Price Of Share Options Forfeited In Share-Based Payment Arrangement, Non-Market Performance Conditions Not Achieved Weighted Average Exercise Price Of Share Options Forfeited In Share-Based Payment Arrangement, Non-Market Performance Conditions Not Achieved Disclosure Of Trade And Other Payables [Line Items] Disclosure Of Trade And Other Payables [Line Items] Disclosure Of Trade And Other Payables Number of PSU and RSU forfeited (in shares) Number of other equity instruments forfeited in share-based payment arrangement Basis of consolidation Description Of Accounting Policy For Basis Of Consolidation Policy [Policy Text Block] Description Of Accounting Policy For Basis Of Consolidation Policy Statistical Measurement [Domain] Statistical Measurement [Domain] Disclosure of Financial Assets at Amortized Cost Disclosure of financial assets [text block] Administrative cost (excl. cost for managing plan assets) Increase (decrease) in net defined benefit liability (asset) resulting from administration costs not reflected in return on plan assets Disclosure of attribution of expenses by nature to their function [table] Disclosure of attribution of expenses by nature to their function [table] Carrying amount [member] Carrying amount [member] Financial Risk Management [Abstract] Financial Risk Management [Abstract] Financial Risk Management [Abstract] Tax loss carryforwards, expiration period Tax Loss Carryforwards, Expiration Period Tax Loss Carryforwards, Expiration Period Change in other current assets Adjustments for decrease (increase) in other current assets Depreciation on right-of-use assets Depreciation, right-of-use assets Taxes Disclosure of income tax [text block] Actuarial assumptions, possible increase (decrease) in longevity for most of the age categories Actuarial Assumptions, Possible Increase (Decrease) In Longevity For Most Of The Age Categories Actuarial Assumptions, Possible Increase (Decrease) In Longevity For Most Of The Age Categories Net finance result Finance income (cost) Exercise price, range three Exercise Price Range Three [Member] Exercise Price Range Three Number of operating segments Number Of Operating Segments Number Of Operating Segments Earnings per share [abstract] Negative interest on financial assets held at amortized costs Negative Interest Revenue For Financial Assets Measured At Amortised Cost Negative Interest Revenue For Financial Assets Measured At Amortised Cost Property, plant and equipment Property, plant and equipment at beginning of period Property, plant and equipment at end of period Property, plant and equipment Royalties and license fees Disclosure Of Royalties And License Fees [Text Block] Disclosure Of Royalties And License Fees Disclosure of credit risk exposure [line items] Disclosure of credit risk exposure [line items] Geographical areas [member] Geographical areas [member] Amgen Amgen, Inc [Member] Amgen, Inc Selling, general and administrative expenses Selling, general and administrative expense Selling, general and administrative expense Disclosure of Financial Liabilities at Amortized Cost Disclosure of financial liabilities [text block] Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] Past service cost Increase (decrease) in net defined benefit liability (asset) resulting from past service cost Intangible assets Disclosure of intangible assets [text block] Number of share options exercisable (in shares) Number of share options exercisable in share-based payment arrangement Document Information [Line Items] Document Information [Line Items] Financial Instruments [Abstract] Financial Instruments [Abstract] Financial Instruments [Abstract] Discount rate Actuarial assumption of discount rates Research and development expenses Research And Development Expense [Member] Research And Development Expense Related party transactions [abstract] Related party transactions [abstract] Proceeds from issuance of new shares, net of transaction costs Proceeds from issuing shares Number of PSU and RSU exercised (in shares) Number of other equity instruments exercised or vested in share-based payment arrangement Classes of share capital [axis] Classes of share capital [axis] Profit or loss [abstract] University of Zurich University Of Zurich [Member] University Of Zurich Net defined benefit liability at December 31 Net defined benefit liability at January 1 Net defined benefit liability at December 31 Fair value of plan assets at January 1 Fair value of plan assets at December 31 Net defined benefit liability (asset) Net defined benefit liability (asset) Other receivables Other current receivables Contributions by plan participants Contributions by plan participants Decrease (increase) in net defined benefit liability (asset) resulting from contributions to plan by plan participants Issued in relation to creation of treasury shares in August 2022 Number Of Shares Issued, Treasury Shares, Equity Number Of Shares Issued, Treasury Shares, Equity Vesting period Vesting Requirements For Share-Based Payment Arrangement, Vesting Period Vesting Requirements For Share-Based Payment Arrangement, Vesting Period Weighted average fair value of rights granted (in CHF per shares) Weighted Average Fair Value Price At Measurement Date, Other Equity Instruments Granted Weighted Average Fair Value Price At Measurement Date, Other Equity Instruments Granted Total current assets Current assets Social security costs Social security contributions Expected revenue recognition in year five and later after balance sheet date Later Than Four Years [Member] Later Than Four Years Geographical areas [axis] Geographical areas [axis] Laboratory equipment Laboratory Equipment [Member] Laboratory Equipment Percentage of reasonably possible decrease in actuarial assumption Percentage of reasonably possible decrease in actuarial assumption General information Disclosure of notes and other explanatory information [text block] Weighted average exercise price of share options expired (in CHF per share) Weighted average exercise price of share options expired in share-based payment arrangement Percentage of reasonably possible increase in actuarial assumption Percentage of reasonably possible increase in actuarial assumption Types of contracts [member] Types of contracts [member] Change in contract liability Adjustments for increase (decrease) in contract liabilities Change in employee benefits Adjustments for increase (decrease) in employee benefit liabilities Intangible assets other than goodwill [abstract] Disclosure of Useful Lives of Property, Plant and Equipment Disclosure of Reconciliation of Changes in Property, Plant and Equipment Disclosure of detailed information about property, plant and equipment [text block] Trade receivables Trade receivables [member] thereof net interest expense on the net defined benefit liability Interest expense (income), defined benefit plans All Currencies [Domain] All Currencies [Domain] Foreign currency translation / transactions Description of accounting policy for foreign currency translation [text block] Total non-current assets Non-current assets Total operating expenses Operating expense Disclosure of detailed information about intangible assets [table] Disclosure of detailed information about intangible assets [table] Risk free interest rate, NBI Risk Free Interest Rate, NBI, Other Equity Instruments Granted Risk Free Interest Rate, NBI, Other Equity Instruments Granted Document Annual Report Document Annual Report Increase (decrease) in authorized share capital Increase (Decrease) In Authorized Share Capital Increase (Decrease) In Authorized Share Capital Legal Entity [Axis] Legal Entity [Axis] Disclosure of disaggregation of revenue from contracts with customers [line items] Disclosure of disaggregation of revenue from contracts with customers [line items] Entity Listings, Exchange [Axis] Entity Listings, Exchange [Axis] Disclosure of attribution of expenses by nature to their function [line items] Disclosure of attribution of expenses by nature to their function [line items] Short-term time deposits Short-term deposits, not classified as cash equivalents Disclosure of terms and conditions of share-based payment arrangement [line items] Disclosure of terms and conditions of share-based payment arrangement [line items] Accrued project costs and royalties Current Accrued Project Costs And Royalties Current Accrued Project Costs And Royalties Disclosure Of Detailed Information About Contract Liability [Table] Disclosure Of Detailed Information About Contract Liability [Table] Disclosure Of Detailed Information About Contract Liability VSAO VSAO [Member] VSAO Revenue that was included in contract liability balance at beginning of period Revenue that was included in contract liability balance at beginning of period Financial assets, class [member] Financial assets, class [member] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Social security Current payables on social security and taxes other than income tax Average number of full-time equivalents Average Number Of Full-Time Equivalent Employees Average Number Of Full-Time Equivalent Employees Interest expenses on defined benefit obligation Interest income on plan assets Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income) Selling, general and administrative expenses Selling, general and administrative expense [member] Document Type Document Type Total contractual cashflows Gross lease liabilities Molecular Partners Inc. Molecular Partners Inc. [Member] Molecular Partners Inc. Accrued expenses Disclosure of accrued expenses and other liabilities [text block] Revenues and other income Revenue [abstract] Number of different Swiss banks Cash Balances Investments, Number Of Different Swiss Banks Cash Balances Investments, Number Of Different Swiss Banks Defined benefit obligation due to reasonably possible increase in actuarial assumption Defined Benefit Obligation Due To Reasonably Possible Increase In Actuarial Assumption Defined Benefit Obligation Due To Reasonably Possible Increase In Actuarial Assumption Applicable tax rate Applicable tax rate Prepaid expenses and accrued income Current prepayments and current accrued income other than current contract assets Exchange (loss) gain on working capital positions Adjustment For Exchange Gains (Losses) On Working Capital Positions Adjustment For Exchange Gains (Losses) On Working Capital Positions Expected revenue recognition in year two after balance sheet date Between 1 and 2 years Later than one year and not later than two years [member] Number of shares authorized, employee participation (in shares) Number Of Shares Authorized, Employee Participation Number Of Shares Authorized, Employee Participation ESOP 2009 and ESOP 2014 ESOP 2009 And ESOP 2014 [Member] ESOP 2009 And ESOP 2014 Depreciation charge for the year Depreciation, property, plant and equipment Product and Service [Domain] Product and Service [Domain] Share capital / Additional paid-in capital Description of accounting policy for issued capital [text block] Leases Description of accounting policy for leases [text block] Entity Shell Company Entity Shell Company Disclosure of detailed information about financial instruments [table] Disclosure of detailed information about financial instruments [table] Disclosure Of Detailed Information About Income Taxes And Deferred Taxes [Table] Disclosure Of Detailed Information About Income Taxes And Deferred Taxes [Table] Disclosure Of Detailed Information About Income Taxes And Deferred Taxes Contributions by the employer Contributions by the employer Decrease (increase) in net defined benefit liability (asset) resulting from resulting from contributions to plan by employer Personnel expenses Disclosure Of Employee Benefits And Share-Based Payments Arrangements [Text Block] Disclosure Of Employee Benefits And Share-Based Payments Arrangements Net cash from (used in) operating activities Cash flows from (used in) operating activities Actuarial assumption of life expectancy Actuarial assumption of life expectancy after retirement [member] Total amount recognized in profit or loss Lease, Cost Recognised In Profit Or Loss Lease, Cost Recognised In Profit Or Loss Office equipment Office equipment [member] Significant transactions Significant Transactions [Member] Significant Transactions Lease liabilities [abstract] Lease liabilities [abstract] Disclosure of transaction price allocated to remaining performance obligations [table] Disclosure of transaction price allocated to remaining performance obligations [table] Document Period End Date Document Period End Date Critical accounting estimates and judgments Disclosure of accounting judgements and estimates [text block] Number of share options forfeited (in shares) Number of share options forfeited in share-based payment arrangement Employee benefits Description of accounting policy for employee benefits [text block] Weighted average exercise price of instruments exercised (in CHF per share) Weighted Average Exercise Price Of Instruments Exercised In Share-Based Payment Arrangement Weighted Average Exercise Price Of Instruments Exercised In Share-Based Payment Arrangement Net defined benefit liability (asset) [member] Net defined benefit liability (asset) [member] Additions / new leases Increase Through New Leases, Operating Leases Increase Through New Leases, Operating Leases Real estate funds Real estate, amount contributed to fair value of plan assets Pensioners Pensioners [Member] Pensioners Pension and share-based compensation costs, non-cash portion Post-Employment Benefit Cost And Share-Based Compensation Cost, Non-Cash Effective Cost Post-Employment Benefit Cost And Share-Based Compensation Cost, Non-Cash Effective Cost Royalty income, percentage Royalty Income, Percentage Royalty Income, Percentage Offset of costs Offset of costs Decrease Through Offset Of Costs, Contract Liabilities Decrease Through Offset Of Costs, Contract Liabilities Total shareholders' equity and liabilities Equity and liabilities Treasury share reserve Treasury shares [member] Financial liabilities, class [member] Financial liabilities, class [member] Applicable estimated useful lives, intangible assets Useful life measured as period of time, intangible assets other than goodwill thereof property occupied or other assets used by the entity Property Occupied Or Other Assets Used By Entity Included In Fair Value Of Plan Assets Property Occupied Or Other Assets Used By Entity Included In Fair Value Of Plan Assets Reservation Agreement with Swiss Federal Office of Public Health Reservation Agreement With Swiss Federal Office Of Public Health [Member] Reservation Agreement With Swiss Federal Office Of Public Health Credit risk Credit risk [member] Number of PSUs and RSUs outstanding (in shares) Number of PSU and RSU outstanding at beginning of period (in shares) Number of PSU and RSU outstanding at end of period (in shares) Number of other equity instruments outstanding in share-based payment arrangement Extended period of reservation agreement Extended Period Of Reservation Agreement Extended Period Of Reservation Agreement No Trading Symbol Flag No Trading Symbol Flag Net cash (used in) from financing activities Cash flows from (used in) financing activities Interest expense on leases Recognition of interest on lease liabilities Interest expense on lease liabilities Interest expense on lease liabilities Net foreign exchange gain Net foreign exchange gain Other personnel expenses Other employee expense Weighted average remaining contractual life of outstanding PSUs and RSUs Weighted Average Remaining Contractual Life Of Outstanding Other Equity Instruments Weighted Average Remaining Contractual Life Of Outstanding Other Equity Instruments Net defined benefit liability (asset) [axis] Net defined benefit liability (asset) [axis] Percentage of share capital registered accumulated Preemptive Rights, Shareholders, Percentage Of Share Capital Registered Accumulated Preemptive Rights, Shareholders, Percentage Of Share Capital Registered Accumulated Lease liability Non-current Non-current lease liabilities Disclosure of terms and conditions of share-based payment arrangement [table] Disclosure of terms and conditions of share-based payment arrangement [table] Expected volatility on Common shares Expected Volatility On Common Shares, Other Equity Instruments Granted Expected Volatility On Common Shares, Other Equity Instruments Granted Weighted average exercise price (in CHF per shares) Weighted average exercise price of PSU and RSU granted (in CHF per share) Weighted average exercise price of other equity instruments granted in share-based payment arrangement Actuarial assumptions Actuarial Assumptions [Abstract] Actuarial Assumptions Number of instruments granted (in shares) Number of instruments granted in share-based payment arrangement Applicable estimated useful lives, property, plant and equipment Useful life measured as period of time, property, plant and equipment Disclosure Of Detailed Information About Cash, Cash Equivalents And Short-Term Time Deposits [Line Items] Disclosure Of Detailed Information About Cash, Cash Equivalents And Short-Term Time Deposits [Line Items] Disclosure Of Detailed Information About Cash, Cash Equivalents And Short-Term Time Deposits Weighted average exercise price of PSU and RSU exercised (in CHF per share) Weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement Return on plan assets excl. interest income Decrease (increase) in net defined benefit liability (asset) resulting from return on plan assets excluding interest income or expense Short-term employee benefits Key management personnel compensation, short-term employee benefits Types of contracts [axis] Types of contracts [axis] Entity Registrant Name Entity Registrant Name Disclosure of disaggregation of revenue from contracts with customers [table] Disclosure of disaggregation of revenue from contracts with customers [table] Changes in number of shares outstanding [abstract] Changes in number of shares outstanding [abstract] Interest rate risk Interest rate risk [member] Disclosure of Timing of Revenue Recognition by Type of Payments Received Disclosure Of Timing Of Revenue Recognition By Type Of Payments Received [Table Text Block] Disclosure Of Timing Of Revenue Recognition By Type Of Payments Received Entity Address, City or Town Entity Address, City or Town Right-of-use assets Right-Of-Use Assets, Property Plant And Equipment [Member] Right-Of-Use Assets, Property Plant And Equipment Contributions by the employer Estimate of contributions expected to be paid to plan for next annual reporting period Individuals [Axis] Individuals [Axis] Individuals Leasehold improvements Leasehold improvements [member] Exchange differences on translating foreign operations Exchange differences on translating foreign operations Other comprehensive income, net of tax, exchange differences on translation of foreign operations Pension costs Defined benefit cost recognized in profit or loss Post-employment benefit expense in profit or loss, defined benefit plans Minimum Minimum [Member] Entity Emerging Growth Company Entity Emerging Growth Company Increase in exchange rates Increase in interest rates Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Increase In Risk Variable, Percent Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Increase In Risk Variable, Percent University of Utrecht University Of Utrecht [Member] University Of Utrecht Auditor Name Auditor Name Trading Symbol Trading Symbol Entity File Number Entity File Number Performance Share Units (PSU) Performance Share Units (PSU) [Member] Performance Share Units (PSU) Cash outflow for leases Payments Cash outflow for leases Shareholders’ equity Disclosure of share capital, reserves and other equity interest [text block] Change in accrued expenses Adjustments For Increase (Decrease) In Accrued Expenses Adjustments For Increase (Decrease) In Accrued Expenses License fees License Fees Expense License Fees Expense Disclosure of detailed information about property, plant and equipment [line items] Disclosure of detailed information about property, plant and equipment [line items] Weighted average exercise price of instruments forfeited (in CHF per share) Weighted Average Exercise Price Of Instruments Forfeited In Share-Based Payment Arrangement Weighted Average Exercise Price Of Instruments Forfeited In Share-Based Payment Arrangement Counterparties [member] Counterparties [member] Cliff vesting percentage Vesting Requirements For Share-Based Payment Arrangement, Cliff Vesting Percentage Vesting Requirements For Share-Based Payment Arrangement, Cliff Vesting Percentage Others Other assets, amount contributed to fair value of plan assets American depositary shares (each representing one common share, CHF 0.10 nominal value per share) American Depository Shares, The Nasdaq Stock Market LLC [Member] American Depository Shares, The Nasdaq Stock Market LLC Disclosure of Contractual Maturities of Financial Liabilities Disclosure of maturity analysis of operating lease payments [text block] Reasonably possible increase in actuarial assumptions, period Reasonably Possible Increase In Actuarial Assumptions, Period Reasonably Possible Increase In Actuarial Assumptions, Period Prepayments Current prepaid expenses Novartis AG, Switzerland License And Collaboration Agreement With Novartis AG [Member] License And Collaboration Agreement With Novartis AG Interest expense on defined benefit obligation Interest expense, defined benefit plans Lease liability Current Current lease liabilities Revenues Switzerland SWITZERLAND Number of votes per share Number Of Votes Per Share Number Of Votes Per Share Short term leases Expense relating to short-term leases for which recognition exemption has been used Total non-current liabilities Non-current liabilities Effect on result before tax if interest rates decrease Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Decrease In Risk Variable, Effect On Result Before Tax Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Decrease In Risk Variable, Effect On Result Before Tax Conditional share capital Conditional Share Capital [Member] Conditional Share Capital Disclosure of Detailed Information about Trade and Other Payables Disclosure Of Detailed Information About Trade And Other Payables [Table Text Block] Disclosure Of Detailed Information About Trade And Other Payables Financial instruments, class [member] Financial instruments, class [member] Weighted average exercise price of share options exercised (in CHF per share) Weighted average exercise price of share options exercised in share-based payment arrangement IT hardware Computer equipment [member] Disclosure of Movements in the Number of PSUs and RSUs Disclosure of number and weighted average exercise prices of other equity instruments [text block] Other comprehensive result Other comprehensive income [abstract] Disclosure of Expiry of Tax Loss Carryforwards Disclosure Of Expiry Of Tax Loss Carryforwards [Table Text Block] Disclosure Of Expiry Of Tax Loss Carryforwards Ranges of exercise prices for outstanding share options [member] Ranges of exercise prices for outstanding share options [member] Full contractual life for RSU and PSU Full Contractual Life, Other Equity Instruments Full Contractual Life, Other Equity Instruments Full-time equivalents at year end Number Of Full-Time Equivalent Employees Number Of Full-Time Equivalent Employees Value added tax Current value added tax payables Number of instruments expired (in shares) Number Of Instruments Expired In Share-Based Payment Arrangement Number Of Instruments Expired In Share-Based Payment Arrangement Lease, term Lease, Term Of Contract Lease, Term Of Contract Net increase (decrease) in cash and cash equivalents Increase (decrease) in cash and cash equivalents after effect of exchange rate changes Property, plant and equipment [member] Property, plant and equipment [member] Authorized share capital, employee participation Authorized Share Capital, Employee Participation Authorized Share Capital, Employee Participation Disclosure of Accrued Expenses Explanatory Disclosure Of Current Accrued Expenses And Other Current Liabilities Explanatory [Table Text Block] Disclosure Of Current Accrued Expenses And Other Current Liabilities Explanatory Revenues, other income and and entity-wide disclosures Disclosure of revenue [text block] Investments in short-term time deposits Purchase Of Investments In Short-Term Time Deposits, Classified As Investing Activities Purchase Of Investments In Short-Term Time Deposits, Classified As Investing Activities Earnings per share Disclosure of earnings per share [text block] Defined benefit obligation at December 31 Defined benefit obligation, at present value Facility expenses Occupancy expense Property, plant and equipment Description of accounting policy for property, plant and equipment [text block] Counterparty Name [Domain] Counterparty Name [Domain] Number of RSU and PSU granted (in shares) Number of other equity instruments granted in share-based payment arrangement Analysis of income and expense [abstract] Revenues from research and development collaborations Total revenues Revenue from contracts with customers Actuarial assumption of discount rates Actuarial assumption of discount rates [member] Proceeds from exercise of stock options, net of transaction costs Proceeds from exercise of options Proceeds from exercise of options Disclosure Of Reconciliation Of Cash, Cash Equivalents And Short-Term Time Deposits [Line Items] Disclosure Of Reconciliation Of Cash, Cash Equivalents And Short-Term Time Deposits [Line Items] Disclosure Of Reconciliation Of Cash, Cash Equivalents And Short-Term Time Deposits Disclosure of detailed information about property, plant and equipment [table] Disclosure of detailed information about property, plant and equipment [table] Reconciliation of amount recognized in OCI Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans [abstract] Plan assets Plan assets [member] Quoted market price Level 1 of fair value hierarchy [member] Entity Interactive Data Current Entity Interactive Data Current Number of instruments exercisable (in shares Number Of Instruments Exercisable In Share-Based Payment Arrangement Number Of Instruments Exercisable In Share-Based Payment Arrangement Number of instruments forfeited (in shares) Number Of Instruments Forfeited In Share-Based Payment Arrangement Number Of Instruments Forfeited In Share-Based Payment Arrangement Disclosure of Compensation Costs of Key Management Disclosure of transactions between related parties [text block] Depreciation and amortization Adjustments for depreciation and amortisation expense Personnel expenses Personnel expenses Employee benefits expense Expected volatility on SPI Expected Volatility On SPI, Other Equity Instruments Granted Expected Volatility On SPI, Other Equity Instruments Granted Upfront payment Upfront Payment Received Upfront Payment Received Change in trade and other receivables Adjustments for decrease (increase) in trade and other receivables Share-based compensation Key management personnel compensation, share-based payment Restricted Share Units (RSU) Restricted Share Units (RSU) [Member] Restricted Share Units (RSU) Number of shares issued (in shares) Number of shares issued Disclosure of Conditions and Inputs Used in the Measurement of the Fair Values at Grant Dates Disclosure of indirect measurement of fair value of goods or services received, other equity instruments granted during period [text block] Interest income on plan assets Interest income, defined benefit plans Currency risk Currency risk [member] Benefits (paid)/deposited Benefits (paid)/deposited Decrease (increase) in net defined benefit liability (asset) resulting from payments from plan Business Contact Business Contact [Member] Disclosure of credit risk exposure [table] Disclosure of credit risk exposure [table] Depreciation and amortization Depreciation and amortisation expense Additions Increase Through Additions, Contract Liabilities Increase Through Additions, Contract Liabilities Other administrative expenses Administrative expenses Share-based compensation (non-cash effective) Share-based compensation (non-cash effective) Expense from share-based payment transactions with employees Disclosure of classes of share capital [table] Disclosure of classes of share capital [table] Licence and Collaboration Agreement with Amgen, Inc Amgen Inc., USA License And Collaboration Agreement With Amgen, Inc [Member] License And Collaboration Agreement With Amgen, Inc Disclosure of Exercise Prices, Number and Weighted Average Remaining Contractual Life of Outstanding Instruments Disclosure Of Exercise Prices, Number And Weighted Average Remaining Contractual Life Of Outstanding Instruments [Table Text Block] Disclosure Of Exercis Price, Number And Weighted Average Remaining Contractual Life Of Outstanding Instruments Weighted average exercise price of PSU and RSU expired (in CHF per share) Weighted average exercise price of other equity instruments expired in share-based payment arrangement Number of PSU and RSU expired (in shares) Number of other equity instruments expired in share-based payment arrangement Trade receivables Trade Payables [Member] Trade Payables Document Shell Company Report Document Shell Company Report Number of share options forfeited, performance adjustment (in shares) Number Of Share Options Forfeited In Share-Based Payment Arrangement, Non-Market Performance Conditions Not Achieved Number Of Share Options Forfeited In Share-Based Payment Arrangement, Non-Market Performance Conditions Not Achieved Disclosure Of Detailed Information About Cash, Cash Equivalents And Short-Term Time Deposits [Table] Disclosure Of Detailed Information About Cash, Cash Equivalents And Short-Term Time Deposits [Table] Disclosure Of Detailed Information About Cash, Cash Equivalents And Short-Term Time Deposits Statistical Measurement [Axis] Statistical Measurement [Axis] Other current assets Other current assets Number of shares authorized, financing transactions (in shares) Number Of Shares Authorized, Financing Transactions Number Of Shares Authorized, Financing Transactions Reconciliation of net defined benefit liability Changes in net defined benefit liability (asset) [abstract] Disclosure of Reconciliation of Cash, Cash Equivalents and Short-Term Time Deposits Disclosure Of Reconciliation Of Cash, Cash Equivalents And Short-Term Time Deposits [Table Text Block] Disclosure Of Reconciliation Of Cash, Cash Equivalents And Short-Term Time Deposits Lease facilities, Schlieren Lease Facilities, Schlieren [Member] Lease Facilities, Schlieren Number of PSUs and RSUs exercisable (in shares) Number of other equity instruments exercisable in share-based payment arrangement Defined benefit obligation due to reasonably possible decrease in actuarial assumption Defined Benefit Obligation Due To Reasonably Possible Decrease In Actuarial Assumption Defined Benefit Obligation Due To Reasonably Possible Decrease In Actuarial Assumption Trade and other receivables Trade and other receivables Trade and other current receivables Actuarial (gain)/loss on defined benefit obligation Actuarial Gains (Losses), Net Of Tax, Defined Benefit Plans Actuarial Gains (Losses), Net Of Tax, Defined Benefit Plans Effect on result before tax if exchange rates increase Effect on result before tax if interest rates increase Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Increase In Risk Variable, Effect On Result Before Tax Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Increase In Risk Variable, Effect On Result Before Tax Maximum amount of share capital increase authorized, percent Maximum Amount Of Share Capital Increase Authorized, Percent Maximum Amount Of Share Capital Increase Authorized, Percent Disclosure of Revenue by Country and by Major Alliance Partner Disclosure of disaggregation of revenue from contracts with customers [text block] Other income Other income Other current assets Disclosure Of Prepaid Expenses And Accrued Income [Text Block] Disclosure Of Prepaid Expenses And Accrued Income Expected dividend Expected Dividend, Other Equity Instruments Granted Expected Dividend, Other Equity Instruments Granted Document Fiscal Year Focus Document Fiscal Year Focus Disclosure Of General Information [Abstract] Disclosure Of General Information [Abstract] Income taxes paid Income taxes paid (refund), classified as operating activities Disclosure Of Detailed Information About Royalties And License Fees [Line Items] Disclosure Of Detailed Information About Royalties And License Fees [Line Items] Disclosure Of Detailed Information About Royalties And License Fees Income taxes Description of accounting policy for income tax [text block] Expected revenue recognition in year four after balance sheet date Later than three years and not later than four years [member] Disclosure of contingent liabilities [abstract] Share capital Issued capital [member] Result before income taxes Profit (loss) before tax Treasury shares Description of accounting policy for treasury shares [text block] Number of instruments exercised (in shares) Number Of Instruments Exercised In Share-Based Payment Arrangement Number Of Instruments Exercised In Share-Based Payment Arrangement Disclosure of Reconciliation of Changes in Intangible Assets Disclosure of detailed information about intangible assets [text block] Royalties, minimum amount required to pay in total Royalties, Minimum Annual Amount, Total Royalties, Minimum Annual Amount, Total Entity Addresses, Address Type [Axis] Entity Addresses, Address Type [Axis] Disclosure of nature and extent of risks arising from financial instruments [line items] Disclosure of nature and extent of risks arising from financial instruments [line items] Reconciliation of fair value of plan assets Reconciliation Of Fair Value Of Plan Assets [Abstract] Reconciliation Of Fair Value Of Plan Assets Disclosure of Movement of Lease Liabilities Disclosure Of Movement Of Lease Liabilities [Table Text Block] Disclosure Of Movement Of Lease Liabilities Issuance of new shares, net of transaction costs Issue of equity Adjustments for: Adjustments to reconcile profit (loss) [abstract] Auditor Firm ID Auditor Firm ID Accrued income Current accrued income other than current contract assets Statement of changes in equity [line items] Statement of changes in equity [line items] Cash and cash equivalents Description of accounting policy for determining components of cash and cash equivalents [text block] Document Transition Report Document Transition Report Local Phone Number Local Phone Number Lease liabilities at beginning of period Lease liabilities at end of period Lease liabilities Carrying Amount lease liabilities Lease liabilities FOPH Federal Office Of Public Health [Member] Federal Office Of Public Health Accrued sabbatical cost Accrued Sabbatical Cost Accrued Sabbatical Cost Number of PSUs issued, in percentage of number of PSUs granted Number Of Other Equity Instruments Issued In Share-Based Payment Arrangement, In Percentage Of Number Granted Number Of Other Equity Instruments Issued In Percentage Of Number Granted Classes of property, plant and equipment [axis] Classes of property, plant and equipment [axis] Ranges of exercise prices for outstanding share options [axis] Ranges of exercise prices for outstanding share options [axis] Segment reporting Description of accounting policy for segment reporting [text block] Ranges [member] Ranges [member] Total shareholders' equity Equity at beginning of period Equity at end of period Equity Equity Document Information [Table] Document Information [Table] Classes of financial instruments [axis] Classes of financial instruments [axis] Actuarial assumption of interest rate on retirement savings capital Actuarial Assumption Of Interest Rate On Retirement Savings Capital [Member] Actuarial Assumption Of Interest Rate On Retirement Savings Capital Disclosure Of Exercise Prices, Number And Weighted Average Remaining Contractual Life Of Outstanding Instruments [Table] Disclosure Of Exercise Prices, Number And Weighted Average Remaining Contractual Life Of Outstanding Instruments [Table] Disclosure Of Exercise Prices, Number And Weighted Average Remaining Contractual Life Of Outstanding Instruments Reasonably possible decrease in actuarial assumptions, period Reasonably Possible Decrease In Actuarial Assumptions, Period Reasonably Possible Decrease In Actuarial Assumptions, Period Exercise of stock options, net of transaction costs Increase (decrease) through exercise of options, equity Non-adjusting events after reporting period [member] Non-adjusting events after reporting period [member] Types of risks [axis] Types of risks [axis] Disclosure Of Detailed Information About Leases [Table] Disclosure Of Detailed Information About Leases [Table] Disclosure Of Detailed Information About Leases [Table] Statement of financial position [abstract] Maximum exposure to credit risk Maximum exposure to credit risk Address Type [Domain] Address Type [Domain] Nominal value of treasury shares Treasury Shares, Nominal Value Treasury Shares, Nominal Value Document Fiscal Period Focus Document Fiscal Period Focus Research consumables and external research and development expenses Research Consumables And External Research And Development Expense Research Consumables And External Research And Development Expense Types of share-based payment arrangements [axis] Types of share-based payment arrangements [axis] Plan asset classes Classes of plan assets, fair value monetary amounts [abstract] Disclosure of Maximum Credit Risk Exposure Disclosure of credit risk exposure [text block] Maximum amount of share capital increase authorized, number of shares (in shares) Maximum Amount Of Share Capital Increase Authorized, Number Of Shares Maximum Amount Of Share Capital Increase Authorized, Number Of Shares Option and Equity Rights Agreement with Novartis Option And Equity Rights Agreement With Novartis, Ensovibep [Member] Option And Equity Rights Agreement With Novartis, Ensovibep Total comprehensive result, attributable to shareholders Comprehensive income (loss) Comprehensive income Additions Additions other than through business combinations, intangible assets other than goodwill Voluntary complementary plan Voluntary Complementary Plan [Member] Voluntary Complementary Plan ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Weighted average exercise price of instruments expired (in CHF per share) Weighted Average Exercise Price Of Instruments Expired In Share-Based Payment Arrangement Weighted Average Exercise Price Of Instruments Expired In Share-Based Payment Arrangement Capital commitments Disclosure of commitments [text block] Disclosure of Non-Cash Costs for Share-Based Payments by Functions Disclosure Of Non-Cash Costs For Share-Based Payments By Functions [Table Text Block] Disclosure Of Non-Cash Costs For Share-Based Payments By Functions Actuarial assumption of expected rates of salary increases Actuarial assumption of expected rates of salary increases [member] Tax loss carryforwards Tax loss carryforwards Tax Loss Carryforwards Tax Loss Carryforwards Additions Additions other than through business combinations, property, plant and equipment Related party disclosures Disclosure of related party [text block] Net operating losses Net Operating Losses Net Operating Losses Contract liability Transaction price allocated to remaining performance obligations Expected revenue recognition in year three after balance sheet date Later than two years and not later than three years [member] Additional paid-in capital Additional paid-in capital [member] Cash and cash equivalents Cash and cash equivalents, amount contributed to fair value of plan assets Disclosure of Detailed Information about Trade and Other Receivables Disclosure Of Detailed Information About Trade And Other Receivables [Table Text Block] Disclosure Of Detailed Information About Trade And Other Receivables Exercise price of outstanding share options (in CHF per share) Exercise price of outstanding share options Actuarial (gain) / loss on changes in financial assumptions Actuarial gains (losses) arising from changes in financial assumptions, net of tax, defined benefit plans Number of potential future dilutive shares (in shares) Instruments With Potential Future Dilutive Effect Not Included In Calculation Of Diluted Earnings Per Share Instruments With Potential Future Dilutive Effect Not Included In Calculation Of Diluted Earnings Per Share Accrued expenses Accrued expenses Current accrued expenses and other current liabilities Risk free interest rate, SPI Risk Free Interest Rate, SPI, Other Equity Instruments Granted Risk Free Interest Rate, SPI, Other Equity Instruments Granted Auditor Information [Abstract] Auditor Information Trade payables Current trade payables Financial assets at amortized costs Description of accounting policy for financial assets [text block] Financial income Finance income Finance income Weighted average exercise price of share options outstanding at beginning of period (in CHF per share) Weighted average exercise price of share options outstanding at end of period (in CHF per share) Weighted average exercise price of share options outstanding in share-based payment arrangement Weighted average number of shares used in computing basic loss per share (in shares) Weighted average number of ordinary shares used in calculating basic earnings per share Disclosure Of Number And Weighted Average Exercise Prices Of Other Equity Instruments [Line Items] Disclosure Of Number And Weighted Average Exercise Prices Of Other Equity Instruments [Line Items] Disclosure Of Number And Weighted Average Exercise Prices Of Other Equity Instruments [Line Items] Performance Share Units (PSU), Management Board Performance Share Units (PSU), Management Board [Member] Performance Share Units (PSU), Management Board Disclosure of transaction price allocated to remaining performance obligations [line items] Disclosure of transaction price allocated to remaining performance obligations [line items] Number of short-term time deposit positions Number Of Short-Term Time Deposit Positions Number Of Short-Term Time Deposit Positions Exercise price of outstanding PSUs and RSUs (in CHF per share) Exercice Price Of Outstanding Other Equity Instruments Exercice Price Of Outstanding Other Equity Instruments Amendment Flag Amendment Flag Disclosure of net defined benefit liability (asset) [line items] Disclosure of net defined benefit liability (asset) [line items] Headcount at year end Number of employees Range [axis] Range [axis] Equity instruments Equity instruments, amount contributed to fair value of plan assets Components of defined benefit cost in profit or loss Post-employment benefit expense in profit or loss, defined benefit plans [abstract] Subclassifications of assets, liabilities and equities [abstract] Cash and cash equivalents Cash and cash equivalents at January 1 Cash and cash equivalents at December 31 Cash and cash equivalents Weighted average share price, at date of exercise (in CHF per share) Weighted Average Share Price In Share-Based Payment Arrangement Exercised During Period, At Date Of Exercise Weighted Average Share Price In Share-Based Payment Arrangement Exercised During Period, At Date Of Exercise Basic net result per share (in CHF per share) Basic earnings (loss) per share Interest income on financial assets held at amortized costs Interest revenue for financial assets measured at amortised cost Transaction costs related to issuance of treasury shares Issuance Costs of Treasury Share Transactions Issuance Costs of Treasury Share Transactions Financial risk management Disclosure of financial risk management [text block] Reconciliation of the amount recognized in the statement of financial position Reconciliation Of The Amount Recognized In The Statement Of Financial Position [Abstract] Reconciliation Of The Amount Recognized In The Statement Of Financial Position Entity Current Reporting Status Entity Current Reporting Status Short-term time deposits Short-Term Time Deposits [Member] Short-Term Time Deposits Number of eligible employees Defined Benefit Plan, Number Of Eligible Employees Defined Benefit Plan, Number Of Eligible Employees Disclosure of Detailed Information about Employee Expenses and Head Count Disclosure Of Detailed Information About Employee Expenses And Head Count [Table Text Block] Disclosure Of Detailed Information About Employee Expenses And Head Count Events after the balance sheet date Disclosure of non-adjusting events after reporting period [text block] Decrease in exchange rates Decrease in interest rates Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Decrease In Risk Variable, Percent Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Decrease In Risk Variable, Percent Post-employment benefits Key management personnel compensation, post-employment benefits Number of share option plans Number Of Share Option Plans Number Of Share Option Plans Reconciliation of defined benefit obligation Reconciliation Of Defined Benefit Obligation [Abstract] Reconciliation Of Defined Benefit Obligation Other financial expenses Other finance cost Contract liabilities [abstract] Exchange gain (loss) on cash positions Effect of exchange rate changes on cash and cash equivalents Counterparty Name [Axis] Counterparty Name [Axis] Amount utilized during period Upfront Payment, Amount Utilized During Period Upfront Payment, Amount Utilized During Period Performance Share Units (PSU), Employees excluding Management Board Performance Share Units (PSU), Employees Excluding Management Board [Member] Performance Share Units (PSU), Employees Excluding Management Board Financial liabilities Financial liabilities Additional paid-in capital Additional paid-in capital Number of shares outstanding (in shares) Shares in issue at start of period Shares in issue at end of period Number of shares outstanding Statement of changes in equity [abstract] Operating result Profit (loss) from operating activities Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Currency [Axis] Currency [Axis] Document Registration Statement Document Registration Statement Maximum amount of share capital increase authorized Maximum Amount Of Share Capital Increase Authorized Maximum Amount Of Share Capital Increase Authorized Withholding tax Current receivables from taxes other than income tax Lease, extension or termination option, period Lease, Extension Or Termination Option, Period Lease, Extension Or Termination Option, Period Decrease through recharge of employee related expenses Revenue From Recharge Of Employee Related Expenses Revenue From Recharge Of Employee Related Expenses Categories of financial assets [axis] Categories of financial assets [axis] Changes in working capital: Changes In Working Capital [Abstract] Changes In Working Capital Thereafter Thereafter [Member] Thereafter CHF CHF Positions Switzerland, Francs Intangible assets Description of accounting policy for intangible assets other than goodwill [text block] Related party fees Services received, related party transactions Capital commitments [abstract] Authorized share capital, financing transactions Authorized Share Capital, Financing Transactions Authorized Share Capital, Financing Transactions Maximum Maximum [Member] Share-based compensation costs Adjustments for share-based payments Net foreign exchange loss Net foreign exchange loss Change in trade and other payables Adjustments for increase (decrease) in trade and other payables Disclosure Of Detailed Information About Income Taxes And Deferred Taxes [Line Items] Disclosure Of Detailed Information About Income Taxes And Deferred Taxes [Line Items] Disclosure Of Detailed Information About Income Taxes And Deferred Taxes Recognized as revenue Recognized as revenue Decrease through performance obligation being satisfied, contract liabilities Expected revenue recognition in year one after balance sheet date Less than 1 year Not later than one year [member] Expected volatility on NBI Expected Volatility On NBI, Other Equity Instruments Granted Expected Volatility On NBI, Other Equity Instruments Granted Disclosure of detailed information about financial instruments [line items] Disclosure of detailed information about financial instruments [line items] Cost Gross carrying amount [member] 2027 Expiring In 2027 [Member] Expiring In 2027 Equity [member] Equity [member] Financial income and financial expense Disclosure of finance income (cost) [text block] Future salary increases at December 31 Actuarial assumption of expected rates of salary increases PSU, RSU and options Share Options, PSUs And RSUs [Member] Share Options, PSUs And RSUs Number of share options outstanding (in shares) Number of share options outstanding at beginning of period (in shares) Number of share options outstanding at end of period (in shares) Number of share options outstanding in share-based payment arrangement Actuarial assumptions [axis] Actuarial assumptions [axis] Trade and other payables Disclosure of trade and other payables [text block] Accrued project costs and royalties Accrued Project Costs And Royalties [Member] Accrued Project Costs And Royalties Title of 12(b) Security Title of 12(b) Security More than 5 years Later than five years [member] Increase (decrease) in authorized share capital, employee participation Increase (Decrease) In Authorized Share Capital, Employee Participation Increase (Decrease) In Authorized Share Capital, Employee Participation Number of instruments outstanding, beginning of period (in shares) Number of instruments outstanding, end of period (in shares) Number of instruments outstanding (in shares) Number Of Instruments Outstanding In Share-Based Payment Arrangement Number Of Instruments Outstanding In Share-Based Payment Arrangement Disclosure of issuance of shares Disclosure of classes of share capital [text block] Other financial expense Other inflows (outflows) of cash, classified as operating activities Operating expenses Operating Expenses [Abstract] Operating Expenses Accrued payroll and bonuses Short-term employee benefits accruals Defined benefit plans [axis] Defined benefit plans [axis] Defined benefit plan, employee contribution Defined Benefit Plan, Employee Contribution Defined Benefit Plan, Employee Contribution Software Computer software [member] Disclosure Of Detailed Information About Employee Benefits [Table] Disclosure Of Detailed Information About Employee Benefits [Table] Disclosure Of Detailed Information About Employee Benefits [Table] Financial income Adjustments for finance income Intellectual property Intellectual Property Expense Intellectual Property Expense Financial assets, category [member] Financial assets, category [member] Risks [member] Risks [member] Disclosure Of Detailed Information About Royalties And License Fees [Table Text Block] Disclosure Of Detailed Information About Royalties And License Fees [Table] Disclosure Of Detailed Information About Royalties And License Fees Licence and Collaboration Agreement with Novartis 2021 License And Collaboration Agreement With Novartis, DARPIN Conjugated Radioligand Therapies [Member] 2021 License And Collaboration Agreement With Novartis, DARPIN Conjugated Radioligand Therapies Exercise price, range four Exercise Price Range Four [Member] Exercise Price Range Four Issued in relation to vesting of PSU, RSU and options Number Of Shares Issued In Share Based Payment Arrangements, Equity Number Of Shares Issued In Share Based Payment Arrangements, Equity Categories of financial liabilities [axis] Categories of financial liabilities [axis] All levels of fair value hierarchy [member] All levels of fair value hierarchy [member] Entity Address, Country Entity Address, Country Current service cost (employer) Increase in net defined benefit liability (asset) resulting from current service cost Potential future milestone payments Potential Future Milestone Payments Potential Future Milestone Payments Disclosure of Expenses Recognised in Profit or Loss Disclosure of additional information about leasing activities for lessee [text block] Blocking period Vesting Requirements For Share-Based Payment Arrangement, Blocking Period Vesting Requirements For Share-Based Payment Arrangement, Blocking Period Commercial supply of products Commercial Supply Of Products [Member] Commercial Supply Of Products Disclosure of nature and extent of risks arising from financial instruments [table] Disclosure of nature and extent of risks arising from financial instruments [table] Other Other current liabilities Weighted average remaining contractual life of outstanding share options Weighted average remaining contractual life of outstanding share options Active members Active Members [Member] Active Members Financial liabilities at amortized costs Description of accounting policy for financial liabilities [text block] Investments in treasury shares Payments to acquire or redeem entity's shares 2025 Expiring In 2025 [Member] Expiring In 2025 Lab equipment Lab Equipment [Member] Lab Equipment Classes of financial assets [axis] Classes of financial assets [axis] Total current liabilities Current liabilities Financial expenses Adjustments for finance costs Auditor Location Auditor Location Other research and development expenses Other Research And Development Expense Other Research And Development Expense Non-quoted market price Level 2 of fair value hierarchy [member] Entity Filer Category Entity Filer Category Disclosure of Expected Revenue Recognition Analysis for Contract Liabilities Disclosure of transaction price allocated to remaining performance obligations [text block] Issued in relation to capital raise in July 2020 Number Of Shares Issued In Relation To Capital Raise, Equity Number Of Shares Issued In Relation To Capital Raise, Equity Revenues USA UNITED STATES Share-based compensation costs Increase (decrease) through share-based payment transactions, equity Value added tax Current value added tax receivables Commitments made by entity, related party transactions Payment For Term Of Employment, Related Party Transactions Payment For Term Of Employment, Related Party Transactions Assets Assets [abstract] Number of PSU and RSU forfeited, performance adjustment (in shares) Number Of Other Equity Instruments Forfeited In Share-Based Payment Arrangement, Non-Market Performance Conditions Not Achieved Number Of Other Equity Instruments Forfeited In Share-Based Payment Arrangement, Non-Market Performance Conditions Not Achieved Security Exchange Name Security Exchange Name Disclosure of net defined benefit liability (asset) [table] Disclosure of net defined benefit liability (asset) [table] Weighted average exercise price of PSU and RSU forfeited (in CHF per share) Weighted average exercise price of other equity instruments forfeited in share-based payment arrangement Payment of lease liabilities Payments of lease liabilities, classified as financing activities Total revenues and other income Revenue Disposals Disposals, property, plant and equipment Financial expenses Finance costs Finance costs Individuals [Domain] Individuals [Domain] Individuals [Domain] Basis of preparation Statement of IFRS compliance [text block] Disclosure of Attribution of Expenses by Nature Disclosure of attribution of expenses by nature to their function [text block] Disclosure of non-adjusting events after reporting period [abstract] New or revised IFRS standards and interpretations Disclosure of expected impact of initial application of new standards or interpretations [text block] Document Accounting Standard Document Accounting Standard Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Disclosure of Current and Non-Current Contract Liabilities Disclosure Of Current And Non-Current Contract Liabilities [Table Text Block] Disclosure Of Current And Non-Current Contract Liabilities Administrative cost excl. cost for managing plan assets Administration costs not reflected in return on plan assets, defined benefit plans Disclosure of Net Defined Benefit Liability (Asset) Disclosure of net defined benefit liability (asset) [text block] Weighted average exercise price of instruments outstanding at beginning of period (in CHF per share) Weighted average exercise price of instruments outstanding at end of period (in CHF per share) Weighted Average Exercise Price Of Instruments Outstanding In Share-Based Payment Arrangement Weighted Average Exercise Price Of Instruments Outstanding In Share-Based Payment Arrangement Statement of cash flows [abstract] Cover [Abstract] Entity Voluntary Filers Entity Voluntary Filers Cash and cash equivalents Cash And Cash Equivalents [Member] Cash And Cash Equivalents Remeasurement of net pension liabilities, net of tax Remeasurement of net pension liabilities Remeasurement of net pension liabilities Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans Weighted average exercise price of share options forfeited (in CHF per share) Weighted average exercise price of share options forfeited in share-based payment arrangement Employee benefits Non-current provisions for employee benefits Defined benefit cost recognized in profit or loss Increase (decrease) in net defined benefit liability (asset) resulting from expense (income) in profit or loss Number of instruments forfeited, performance adjustment (in shares) Number Of Instruments Forfeited In Share-Based Payment Arrangement, Non-Market Performance Conditions Not Achieved Number Of Instruments Forfeited In Share-Based Payment Arrangement, Non-Market Performance Conditions Not Achieved Classes of intangible assets other than goodwill [axis] Classes of intangible assets other than goodwill [axis] Revenue recognition Description of accounting policy for recognition of revenue [text block] Proceeds from investments in short-term time deposits Proceeds From Investments In Short-Term Time Deposits, Classified As Investing Activities Proceeds From Investments In Short-Term Time Deposits, Classified As Investing Activities Attribution of expenses by nature to their function [axis] Attribution of expenses by nature to their function [axis] Impairment of non-financial assets Description of accounting policy for impairment of non-financial assets [text block] Number of share options exercised (in shares) Number of share options exercised in share-based payment arrangement Disclosure Of Detailed Information About Leases [Line Items] Disclosure Of Detailed Information About Leases [Line Items] Disclosure Of Detailed Information About Leases [Line Items] Disclosure Of Trade And Other Payables [Table] Disclosure Of Trade And Other Payables [Table] Disclosure Of Trade And Other Payables Exercise price, range two Exercise Price Range Two [Member] Exercise Price Range Two Total liabilities Liabilities Disclosure Of Number And Weighted Average Exercise Prices Of Other Equity Instruments [Table] Disclosure Of Number And Weighted Average Exercise Prices Of Other Equity Instruments [Table] Disclosure Of Number And Weighted Average Exercise Prices Of Other Equity Instruments [Table] Lease liabilities Lease liabilities [member] Net cash used in investing activities Cash flows from (used in) investing activities Contract liability Non-current Non-current contract liabilities Share capital Issued capital Current Fiscal Year End Date Current Fiscal Year End Date Property, plant and equipment Disclosure of property, plant and equipment [text block] Actuarial (gain) / loss arising from experience adjustments Actuarial gains (losses) arising from experience adjustments, net of tax, defined benefit plans Amortization charge for the year Amortisation, intangible assets other than goodwill Components of equity [axis] Components of equity [axis] Return on plan assets excluding interest income Return on plan assets excluding interest income or expense, net of tax, defined benefit plans Royalties and license fees Royalties And License Fees Expense Royalties And License Fees Expense 2026 Expiring In 2026 [Member] Expiring In 2026 Weighted average exercise price of share options granted (in CHF per share) Weighted average exercise price of share options granted in share-based payment arrangement Number of tranches Vesting Requirements For Share-Based Payment Arrangement, Number Of Tranches Vesting Requirements For Share-Based Payment Arrangement, Number Of Tranches Cumulative losses Retained earnings [member] Contact Personnel Name Contact Personnel Name Remeasurements Increase (Decrease) Through Remeasurements Of Leases, Operating Leases Increase (Decrease) Through Remeasurements Of Leases, Operating Leases Actuarial assumptions [member] Actuarial assumptions [member] Acquisition of property, plant and equipment Purchase of property, plant and equipment, classified as investing activities Shareholders' equity and liabilities Equity and liabilities [abstract] Disclosure Of Detailed Information About Employee Benefits [Line Items] Disclosure Of Detailed Information About Employee Benefits [Line Items] Disclosure Of Detailed Information About Employee Benefits [Line Items] Disposals Disposals, intangible assets other than goodwill Line items by function [member] Line items by function [member] Putative Class Action Disclosure of contingent liabilities [text block] Trade and other payables Trade and other payables Trade and other current payables Non-adjusting events after reporting period [axis] Non-adjusting events after reporting period [axis] Trade receivables Current trade receivables Entity Ex Transition Period Entity Ex Transition Period thereof service cost and administrative cost Service Cost And Administrative Cost, Defined Benefit Plans Service Cost And Administrative Cost, Defined Benefit Plans Disclosure of Defined Benefit Plan, Expense Recognized in Profit or Loss and Other Comprehensive Income Disclosure Of Defined Benefit Plan, Expense Recognized In Profit Or Loss And Other Comprehensive Income Explanatory [Table Text Block] Disclosure Of Defined Benefit Plan, Expense Recognized In Profit Or Loss And Other Comprehensive Income Explanatory Disclosure of Other Current Assets Disclosure Of Detailed Information About Prepaid Expenses And Accrued Income [Table Text Block] Disclosure Of Detailed Information About Prepaid Expenses And Accrued Income Explanation of Changes in Contract Liabilities Explanation of significant changes in contract assets and contract liabilities [text block] Entity Address, Address Line One Entity Address, Address Line One Past service cost Past service cost, defined benefit plans Royalty Royalty expense Number of banks where deposits are held Number Of Banks Where Deposits Are Held Number Of Banks Where Deposits Are Held Summary of significant accounting policies Disclosure of significant accounting policies [text block] Intangible assets other than goodwill [member] Intangible assets other than goodwill [member] Other comprehensive result, net of tax Other comprehensive income Contract liability Current Current contract liabilities Product and Service [Axis] Product and Service [Axis] Income Taxes And Deferred Taxes [Abstract] Income Taxes And Deferred Taxes [Abstract] Income taxes [Abstract] Disclosure Of Reconciliation Of Cash, Cash Equivalents And Short-Term Time Deposits [Table] Disclosure Of Reconciliation Of Cash, Cash Equivalents And Short-Term Time Deposits [Table] Disclosure Of Reconciliation Of Cash, Cash Equivalents And Short-Term Time Deposits Exchange [Domain] Exchange [Domain] thereof entity's own transferable financial instruments Entity's own financial instruments included in fair value of plan assets Contract liability Disclosure of revenue from contracts with customers [text block] Net operating profit Net Operating Profit Net Operating Profit Salaries Wages and salaries Intangible assets Intangible assets at beginning of period Intangible assets at end of period Intangible assets other than goodwill Remeasurement of net pension liabilities Actuarial (gain)/loss on defined benefit obligation Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income Lease, extension term Lease, Extension Term Of Contract Lease, Extension Term Of Contract USD USD Positions United States of America, Dollars Items that are or may be reclassified subsequently to profit or loss Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract] Net result, attributable to shareholders Net result attributable to shareholders Net result Profit (loss) Financial assets at amortized costs Financial assets at amortised cost, category [member] Disclosure of maturity analysis of operating lease payments [line items] Disclosure of maturity analysis of operating lease payments [line items] Percentage of VSAO contributions in total company's defined benefit plans Percentage Of VSAO Contributions In Total Company's Defined Benefit Plans Percentage Of VSAO Contributions In Company's Total Defined Benefit Contributions Critical Accounting Estimates and Judgments [Abstract] Critical Accounting Estimates and Judgments [Abstract] Interest paid Interest paid, classified as operating activities Vesting, percent Vesting Requirements For Share-Based Payment Arrangement, Percent Vesting Requirements For Share-Based Payment Arrangement, Percent 2024 Expiring In 2024 [Member] Expiring In 2024 Contract liability at beginning of period Contract liability at end of period Contract liability Contract liability Contract liabilities Diluted net result per share (in CHF per share) Diluted earnings (loss) per share Disclosure of Detailed Information about Financial Expense Disclosure Of Detailed Information About Financial Expense [Table Text Block] Disclosure Of Detailed Information About Financial Expense Between 2 and 5 years Later than two years and not later than five years [member] Leases Disclosure of leases [text block] Summary of Weighted Average Number of Shares Used in Computation Earnings per share [text block] Property, plant and equipment [abstract] Par value per share (in CHF per share) Par value per share Issuance of treasury shares incl. transaction costs Increase (decrease) through treasury share transactions, equity Financial assets Financial assets Share capital [member] Share capital [member] Interest received Interest received, classified as investing activities Current service cost (employer) Current service cost, defined benefit plans Common shares Ordinary shares [member] Key management personnel compensation costs Key management personnel compensation Income taxes Tax expense (income) Disclosure of maturity analysis of operating lease payments [table] Disclosure of maturity analysis of operating lease payments [table] Trade and other receivables Disclosure of trade and other receivables [text block] Accumulated depreciation Accumulated depreciation and amortisation [member] Entity Central Index Key Entity Central Index Key Weighted average exercise price of instruments granted (in CHF per share) Weighted Average Exercise Price Of Instruments Granted In Share-Based Payment Arrangement Weighted Average Exercise Price Of Instruments Granted In Share-Based Payment Arrangement Defined benefit plan, employer contribution Defined Benefit Plan, Employer Contribution Defined Benefit Plan, Employer Contribution Sensitivity Analysis to Reasonable Possible Change in Exchange Rates and Interest Rates Sensitivity analysis for types of market risk [text block] Maturity [axis] Maturity [axis] Weighted average duration of defined obligation in years at December 31 Weighted average duration of defined benefit obligation Other non-employee related accrued expenses Other Non-Employee Related Accrued Expenses [Member] Other Non-Employee Related Accrued Expenses Share-based payment arrangements [member] Share-based payment arrangements [member] Entity [Domain] Entity [Domain] Aggregated time bands [member] Aggregated time bands [member] City Area Code City Area Code Weighted average number of shares used in computing diluted loss per share (in shares) Weighted average number of ordinary shares used in calculating diluted earnings per share Financial liabilities at amortized cost Financial liabilities at amortised cost, category [member] Number of share options expired (in shares) Number of share options expired in share-based payment arrangement FOPH, Switzerland License And Collaboration Agreement With FOPH [Member] License And Collaboration Agreement With FOPH Items that will not be reclassified to profit or loss Components of other comprehensive income that will not be reclassified to profit or loss, net of tax [abstract] EUR EUR Positions Euro Member Countries, Euro Equity [abstract] Equity [abstract] Disclosure Of Trade And Other Receivables [Table] Disclosure Of Trade And Other Receivables [Table] Disclosure Of Trade And Other Receivables [Table] 2023 Expiring In 2023 [Member] Expiring In 2023 Financial instruments Disclosure of financial instruments [text block] Disclosure Of Significant Accounting Policies [Abstract] Disclosure Of Significant Accounting Policies [Abstract] Accounting Policies [Abstract] Total assets Assets Cliff vesting period Vesting Requirements For Share-Based Payment Arrangement, Cliff Vesting Period Vesting Requirements For Share-Based Payment Arrangement, Cliff Vesting Period Disclosure of Detailed Information about Financial Income Disclosure Of Detailed Information About Financial Income [Table Text Block] Disclosure Of Detailed Information About Financial Income Exercise price, range one Exercise Price Range One [Member] Exercise Price Range One Financial liabilities, category [member] Financial liabilities, category [member] Cash, cash equivalents and short-term time deposits Disclosure Of Cash, Cash Equivalents And Short-Term Time Deposits [Text Block] Disclosure Of Cash, Cash Equivalents And Short-Term Time Deposits Defined benefit plans [member] Defined benefit plans [member] Weighted average exercise price of PSU and RSU outstanding at beginning of period (in CHF per share) Weighted average exercise price of PSU and RSU outstanding at end of period (in CHF per share) Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement Accrued income Accrued Income [Member] Accrued Income Maximum percentage of total number of shares in a placement Preemptive Rights, Over-Allotment Option, Maximum Percentage Of Total Number Of Shares In A Placement Preemptive Rights, Over-Allotment Option, Maximum Percentage Of Total Number Of Shares In A Placement Actuarial (gain) / loss on changes in demographic assumptions Actuarial gains (losses) arising from changes in demographic assumptions, net of tax, defined benefit plans Defined benefit obligation Present value of defined benefit obligation [member] Additional information on the nature of expenses Disclosure of expenses by nature [text block] Current tax expense (income) Current tax expense (income) Weighted average exercise price of PSU and RSU forfeited, performance adjustment (in CHF per share) Weighted Average Exercise Price Of Other Equity Instruments Forfeited In Share-Based Payment Arrangement, Non-Market Performance Conditions Not Achieved Weighted Average Exercise Price Of Other Equity Instruments Forfeited In Share-Based Payment Arrangement, Non-Market Performance Conditions Not Achieved Issued in relation to Novartis agreement in October 2020 Number Of Shares Issued In Relation To License And Collaboration Agreement, Equity Number Of Shares Issued In Relation To License And Collaboration Agreement, Equity Debt instruments (e.g. bonds) Debt instruments, amount contributed to fair value of plan assets Research and development expenses Description of accounting policy for research and development expense [text block] Personnel Expenses [Abstract] Personnel Expenses [Abstract] Personnel Expenses [Abstract] Disclosure of Movements in the Number of Share Options Disclosure of number and weighted average exercise prices of share options [text block] Risk free interest rate, common shares Risk Free Interest Rate, Common Share, Other Equity Instruments Granted Risk Free Interest Rate, Common Share, Other Equity Instruments Granted Statement of changes in equity [table] Statement of changes in equity [table]